Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
198.60    -4.00 (-1.97%)
Bid:
198.50
Ask:
199.00
Spread: 0.50 (0.252%)
Market Cap: £1.29b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

15 Jan 2021 07:00

RNS Number : 7739L
Ashmore Group PLC
15 January 2021
 

Ashmore Group plc15 January 2021

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2020.

Assets under management

Theme

Actual30 September 2020

(US$ billion)

Estimated31 December 2020

(US$ billion)

Movement

(%)

External debt

17.6

19.3

+10%

Local currency

18.7

20.6

+10%

Corporate debt

11.1

11.6

+5%

Blended debt

23.2

24.7

+6%

Equities

5.1

6.5

+27%

Alternatives

1.4

1.3

-7%

Multi-asset

0.3

0.3

-

Overlay / liquidity

8.1

8.7

+7%

Total

85.5

93.0

+9%

 

Assets under management increased by US$7.5 billion over the period, comprising positive investment performance of US$8.1 billion and net outflows of US$0.6 billion.

Client activity was comparable to the previous quarter. There were net inflows in the overlay / liquidity, external debt and equities themes, reflecting both new client wins and higher allocations to existing mandates, particularly in investment grade credit. The blended debt, corporate debt and local currency themes saw net outflows, which were concentrated in European and US intermediary retail channels. Additionally, US$0.2 billion was returned to investors following successful realisations in the alternatives theme.

Against a backdrop of positive performance by Emerging Markets in the quarter, Ashmore's active investment processes delivered outperformance across its broad range of fixed income and equities strategies. High absolute performance was delivered in the local currency, blended debt, equities, external debt and corporate debt themes. Continuing the trend seen since the market recovery began in April, Ashmore's one- and three-year performance track records showed further improvement over the quarter, and the five-year performance remains very strong.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Ashmore continued to deliver strong relative investment performance over the quarter and current equity and fixed income valuations in Emerging Markets suggest there is much further to go in terms of recovery investment returns. The strong outperformance delivered over the past three quarters provides a firm basis for Ashmore's investment processes to deliver further absolute and relative performance for clients.

"While COVID will continue to affect individual countries differently, the deployment of vaccines supports the view that 2021 will see improved growth and importantly the growth in emerging countries is forecast to be higher than in the developed world. This therefore provides an opportunity for investors to increase exposure to higher return Emerging Markets asset classes and to benefit from economic and market recoveries as they continue to develop in 2021."

 

Notes

For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.3670 at 31 December 2020 (30 June 2020: 1.2356; 31 December 2019: 1.3248). For the translation of US dollar management fees, the average GBP:USD exchange rate achieved for the first half of the financial year was 1.3107 (H1 2019/20: 1.2657).

Ashmore will announce its interim results in respect of the six months ending 31 December 2020 on 10 February 2021.

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingNeil Doyle +44 (0)20 3727 1141Laura Ewart +44 (0)20 3727 1160

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVDLSISLIL
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.